What it is
An FDA warning letter is a public communication from the U.S. Food and Drug Administration telling a business that it appears to be violating regulations. In the stem cell field, these letters have generally concerned products that were being marketed or used without the required approval or oversight. A warning letter is not a court verdict, but it signals that the agency has serious concerns.
The clearly FDA-approved use of stem cells is blood-forming stem cell transplantation, using cord blood or bone marrow, for certain cancers and blood disorders. These are carried out under specialized medical supervision. This is the line to keep clear: that approved use is very different from other products sold under the stem cell label.
Stem cell, mesenchymal stem cell (MSC), bone marrow aspirate, adipose-derived (fat-derived), umbilical cord or Wharton's jelly, and exosome products marketed for joints, back pain, sports injuries, skin, anti-aging, or hair loss are generally NOT FDA-approved for those uses. The FDA has warned the public about unapproved stem cell clinics and products. Anyone considering such a product should ask a licensed clinician about its exact regulatory status.
How it’s traditionally been approached
Traditionally, medical products that are meant to treat or affect the body go through a regulatory pathway in which safety and effectiveness are evaluated before they are widely marketed. Blood-forming stem cell transplants followed this kind of path for specific conditions and remain the established use.
When a clinic markets cell-based or exosome products outside that pathway, the FDA may inspect, issue public warnings, or send letters asking the business to correct its practices. Some businesses respond, and others dispute the agency's view. Reading a letter itself, usually posted publicly by the FDA, can show what the agency objected to.
Many people also look to registered clinical trials, which are research studies that operate under oversight. ClinicalTrials.gov is the public registry where such studies are generally listed. A registered trial is a legitimate route to experimental care, though eligibility, risks, and uncertain benefit should be reviewed carefully with a licensed clinician.
How the right provider may help
The right provider may help you sort through marketing claims and understand where a specific product sits regulatorily. A visit with a licensed clinician generally involves reviewing your health history, discussing your goals, and explaining what options exist, including established care and the option of doing nothing. No outcome can be promised.
Useful questions to ask include: What exactly is the product, and where does it come from? What is its FDA status for this use? What are the specific risks? What is the realistic chance of benefit? Is there a registered clinical trial instead? What is the total cost, and may I take time or get a second opinion?
Informed consent should cover the exact product and its FDA status, specific risks, a realistic chance of benefit, alternatives including doing nothing, total cost disclosure, and your right to walk away. This page is not a consent form. Consent happens between you and your licensed clinician. Providers.plus lists licensed providers, and regenerative and wellness clinics or blood-forming stem cell transplant programs may be among those you explore.
The whole-person view
Health decisions affect the whole person. Pain, illness, and worry about aging can feed stress, and stress can in turn affect sleep, mood, and how the body feels. When someone is hurting, a confident promise can be tempting, which is why slowing down and asking questions is a form of self-care.
Body-based support, such as the approaches offered through Somatic Experiences, may help some people build awareness of how stress lives in the body. Talking with a licensed counselor through Therapists.plus may help with the worry and decision pressure that often come with chronic conditions. These are supportive options, not substitutes for medical evaluation.
Somatic Experiences: nervous system regulation →Somatic Experiences: embodiment and movement →Therapists.plus: mind body connection →
Keep in mind
- Only a licensed clinician can decide what is appropriate for you after an evaluation, and licensed professionals should guide care for serious conditions such as cancer or blood disorders.
- Reported risk categories for unapproved products include infection, immune reaction, tumor formation at the injection site, and permanent injury, including when products are injected into the eye or spine. Red flags include guarantees of results, 'cure' or 'regrow' language, refusing to name the product or its FDA status, pressure to decide quickly, and discouraging a second opinion.
- Treatment abroad (medical tourism) carries materially higher risk because safety, sourcing, and regulatory standards differ and complications are harder to address from a distance. A vetted domestic provider is a safer first step. To report a suspected problem, you can use the FDA's MedWatch safety reporting program and your state medical board.
- For emergencies call 911; in a crisis call or text 988.
Not sure where to start? Answer a few gentle questions and choose who you’d like to hear from.
Frequently asked questions
What is a stem cell therapy FDA warning letter?
A stem cell therapy FDA warning letter is a formal notice from the FDA telling a clinic or company that its product or practices appear to violate federal rules. It is not a court ruling, but it signals serious regulatory concern. The FDA generally makes these letters public.
Is stem cell therapy FDA-approved?
Only some uses are. Blood-forming stem cell transplants from cord blood or bone marrow, used for certain cancers and blood disorders, are the clearly FDA-approved use. Stem cell, MSC, fat-derived, umbilical cord, and exosome products marketed for joints, back pain, skin, anti-aging, or hair loss are generally not FDA-approved for those uses.
Why does the FDA send warning letters to stem cell clinics?
The FDA sends them when it believes a clinic is marketing or using products without required approval or oversight, or in ways that raise safety concerns. The aim is to prompt correction and protect the public. The FDA has also issued general public warnings about unapproved stem cell products.
What are the risks of unapproved stem cell products?
Reported risk categories include infection, immune reaction, tumor formation at the injection site, and permanent injury from unapproved products injected into the eye or spine. A licensed clinician can explain how these apply to a specific product. No outcome is guaranteed.
What are red flags when choosing a stem cell clinic?
Warning signs include guarantees of results, 'cure' or 'regrow' language, refusal to name the product or its FDA status, pressure to decide quickly, and discouraging a second opinion. Hidden or unclear total costs are also a concern. If you notice these, pause and consult another licensed clinician.
How do I report a problem with a stem cell treatment?
You can report a suspected problem through the FDA's MedWatch safety reporting program and by contacting your state medical board. Describe what product was used, where, and what happened. If it is an emergency, call 911; in a crisis, call or text 988.
Educational resource. Safe Stem Cells shares general information and connects people with independent providers. It is not medical advice, diagnosis or treatment. Talk with a licensed professional about your health.